Celltrion's Truxima leads U.S. prescription market in Feb.
SEOUL, April 7 (Yonhap) -- Celltrion Inc., a leading South Korean biopharmaceuti...
Original Source
Read the full article at En →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.